Structure via PubChem · Public domain (PubChem)
ganciclovir
Sign in to saveAlso known as Vitrasert, GA2, 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one, Ganciclovirum, 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one, 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, 2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol, Gancyclovir
Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections.
Chemical data
- Formula
- C9H13N5O4
- Molecular weight
- 255.23 g/mol
- IUPAC name
- 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-1H-purin-6-one
- SMILES
- C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
- InChIKey
- IRSCQMHQWWYFCW-UHFFFAOYSA-N
- XLogP
- -2.5
- Polar surface area
- 135 Ų
- H-bond donors
- 4
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
~4 min read
Encyclopedic overview
10 sectionsContents
- Medical use
- Veterinary use
- Adverse effects
- Toxicity
- Mechanism of action
- Pharmacokinetics
- Administration
- See also
- References
- Further reading
Ganciclovir, sold under the brand name Cytovene among others, is an antiviral medication used to treat cytomegalovirus (CMV) infections.
Ganciclovir was patented in 1980 and approved for medical use in 1988.
Excerpted from Wikipedia’s “ganciclovir” article, available under the CC BY-SA 4.0 licence.